UGI Announces Results of Final Remarketing of 0.125% Series A Cumulative Perpetual Convertible Preferred Stock and Settlement Rate for Purchase Contracts Forming Part of its Corporate Units marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Certain Class A Convertible Preferred Stock of Fate Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024. These Class A Convertible Preferred Stock will be under lockup for 61.
Zapata AI Announces First Quarter 2024 Financial Results and Provides Business Update marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.